Insider · CIK 0002042847
Wendy B. Young
Files at ADIL (ADIAL PHARMACEUTICALS, INC.), RAPP (Rapport Therapeutics, Inc.). First filing Sep 11, 2025, latest Sep 11, 2025.
Wendy B. Young files SEC Form 4 as director at RAPP (Rapport Therapeutics, Inc.), and also at ADIL (ADIAL PHARMACEUTICALS, INC.). Since Sep 11, 2025, Wendy B. Young has reported 1 open-market buy worth $79k and 0 open-market sells worth $0, the latest filed on Sep 11, 2025.
A track record needs three past buys with six months of prices behind them; Wendy B. Young has 0, so none is measured yet.
The newest scored trade: bought $79k of RAPP on Sep 11, 2025, filed Sep 11, 2025, scored 53 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RAPP: Rapport Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | Rapport Therapeutics, Inc. | $79k 3,500 shares | +58% | +224% from low-26% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | AGrant or award Stock Option (Right to Buy)derivative | +25,666 | $0.00 | $0 | 25,666 | 22 d ago |
| Jun 12, 2026 | ADIL ADIAL PHARMACEUTICALS, INC. | POpen-market purchase Pre-funded Warrantderivative | +36,378 | $2.75 | $100k | 36,378 | Jun 16, 2026 |
| Sep 11, 2025 | RAPP Rapport Therapeutics, Inc. | POpen-market purchase Common Stock | +3,500 | $22.60 | $79k | 9,500 | Sep 11, 2025 |
| Jun 17, 2025 | RAPP Rapport Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +10,925 | $0.00 | $0 | 10,925 | Jun 18, 2025 |
| Nov 7, 2024 | RAPP Rapport Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +29,756 | $0.00 | $0 | 29,756 | Nov 7, 2024 |
Questions about Wendy B. Young
Answered from the filings on this page, as of the latest one.
Is Wendy B. Young buying or selling?
Not in the last 12 months. Wendy B. Young's latest open-market trade on SEC Form 4 was bought $79k of RAPP on Sep 11, 2025.
How did Wendy B. Young's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Wendy B. Young has 0.
Where does Wendy B. Young file Form 4?
Wendy B. Young has filed Form 4 at RAPP (Rapport Therapeutics, Inc.); ADIL (ADIAL PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.